DekaBank Deutsche Girozentrale’s Evolent Health EVH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,800	Closed	-$211K	–	1367
2021 Q4	$211K	Hold	7,800	–	–	﹤0.01%	1263
2021 Q3	$231K	Hold	7,800	–	–	﹤0.01%	1180
2021 Q2	$161K	Hold	7,800	–	–	﹤0.01%	1262
2021 Q1	$155K	Buy	+7,800	New	+$148K	﹤0.01%	1231
2020 Q1	–	Sell	-12,061	Closed	-$105K	–	1092
2019 Q4	$105K	Buy	+12,061	New	+$98K	﹤0.01%	1031
2019 Q3	–	Sell	-12,061	Closed	-$95K	–	1035
2019 Q2	$95K	Buy	12,061 +5,856	+94%	+$69.3K	﹤0.01%	1088
2019 Q1	$156K	Sell	6,205 -1,369	-18%	-$21.7K	﹤0.01%	1069
2018 Q4	$147K	Buy	7,574 +1,369	+22%	+$31.7K	﹤0.01%	1009
2018 Q3	$156K	Buy	6,205 +4,355	+235%	+$104K	﹤0.01%	1092
2018 Q2	$41K	Hold	1,850	–	–	﹤0.01%	1161
2018 Q1	$26K	Buy	+1,850	New	+$26.5K	﹤0.01%	1137

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

DekaBank Deutsche Girozentrale's EVH Position: Q1 2022 in Review

DekaBank Deutsche Girozentrale sold out of Evolent Health (EVH) in Q1 2022, closing a stake of 7,800 shares — an estimated $211K sold.

DekaBank Deutsche Girozentrale first reported a position in EVH in Q1 2018 and held it in 11 quarters. The position peaked at $231K in Q3 2021. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

DekaBank Deutsche Girozentrale reported no remaining Evolent Health position as of Q1 2022 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 7,800 Evolent Health shares in Q1 2022, an estimated $211K.
DekaBank Deutsche Girozentrale first reported a position in Evolent Health in Q1 2018 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Evolent Health position peaked at $231K in Q3 2021.
218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2022, filed 28 Apr 2022.